“Comparison of the GLP-1 Receptor Agonists with other anti-obesity/anti-diabetic medicines: a systematic review” (2025) Review Journal of Neurological & Medical Sciences Review, 3(5), pp. 347–368. doi:10.63075/w16p9p55.